Array BioPharma Names Gwen A. Fyfe, M.D. to Board of Directors
Array BioPharma Inc. (NASDAQ: ARRY) announced that it has elected Gwen A. Fyfe, M.D., to its Board of Directors. Dr. Fyfe is an oncology biotechnology veteran with more than 20 years of drug development experience.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.